Related Experiment Videos
Effect of local anti-VEGF antibody treatment on tumor microvessel permeability
H C Lichtenbeld1, N Ferarra, R K Jain
1Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Abstract:
Recent studies have shown that systemic injection of anti-VEGF antibody into tumor-bearing mice results in decreases in tumor vascular permeability, vessel diameters, and tumor regression. Using a similar animal model, we have applied anti-VEGF antibody directly to the tumor tissue growing in transparent window chambers in SCID mice. Similar to the results obtained with systemic injection, vascular permeability was greatly reduced, but the response was reached at much lower concentrations with local application. Implications of these findings on local control of tumors are discussed.
Insights
Directly applying anti-VEGF antibody to tumors reduced vascular permeability more effectively than systemic injection. This localized approach shows promise for enhancing local tumor control with lower drug concentrations.
Area of Science:
- Oncology
- Vascular Biology
- Pharmacology
Background:
- Vascular Endothelial Growth Factor (VEGF) plays a critical role in tumor angiogenesis and vascular permeability.
- Systemic administration of anti-VEGF antibodies has demonstrated efficacy in reducing tumor vascular permeability and promoting regression.
- Understanding localized delivery strategies is crucial for optimizing anti-cancer therapies.
Purpose of the Study:
- To investigate the efficacy of directly applying anti-VEGF antibody to tumor tissue.
- To compare the effects of local versus systemic anti-VEGF antibody administration on tumor vascular permeability.
- To assess the potential of localized anti-VEGF therapy for improved tumor control.
Main Methods:
- Utilized a SCID mouse model with tumors grown in transparent window chambers.
- Administered anti-VEGF antibody directly to the tumor tissue.
- Monitored changes in tumor vascular permeability and vessel diameter.
- Compared outcomes with previous studies using systemic anti-VEGF antibody injection.
Main Results:
- Local application of anti-VEGF antibody significantly reduced tumor vascular permeability.
- Effective reduction in vascular permeability was achieved at much lower concentrations with local delivery compared to systemic injection.
- Tumor regression was observed, consistent with systemic administration findings.
Conclusions:
- Direct, localized application of anti-VEGF antibody is an effective strategy for reducing tumor vascular permeability.
- Localized delivery offers a more concentrated and potentially more efficient therapeutic approach.
- These findings suggest significant implications for enhancing local tumor control through targeted anti-VEGF antibody delivery.